Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000899140-06-001391
Filing Date
2006-10-16
Accepted
2006-10-16 11:42:24
Documents
2
Group Members
DANIEL S. LOEBTHIRD POINT OFFSHORE FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 n3440750b.txt SC 13D/A 17210
3 LETTER FROM MANAGEMENT COMPANY TO THE COMPANY n3440750c.txt EX-99.1 4384
  Complete submission text file 0000899140-06-001391.txt   23972
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Subject) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: SC 13D/A | Act: 34 | File No.: 005-31596 | Film No.: 061145529
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 390 PARK AVENUE NEW YORK NY 10022
Business Address 390 PARK AVENUE NEW YORK NY 10022 2122247400
Third Point LLC (Filed by) CIK: 0001040273 (see all company filings)

EIN.: 133922602 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A